Similar results were found by Yang et al., which indicated that a once‐daily premixed insulin analog had a noninferior efficacy on HbA1c reduction in Chinese and Japanese T2DM patients uncontrolled with metformin and a sulfonylurea.17 The gene discussed is INS; the disease is type 2 diabetes mellitus.